Thrombotic events that frequently occur in COVID-19 are predominantly venous
thromboemboli (VTE) and are associated with increasing disease severity and worse clinical …

Mechanisms of immunothrombosis in COVID-19 : Current Opinion in Hematology
Mechanisms of immunothrombosis in COVID-19 : Current Opinion in Hematology Log in or …

Vascular endothelial injury is a hallmark of acute infection at both the microvascular and
macrovascular levels. The hallmark of SARS‐CoV‐2 infection is the current COVID‐19 …

Abstract Background COVID-19-associated coagulopathy (CAC) characterized by the
elevated D-dimer without remarkable changes of other global coagulation markers is …

An ongoing global pandemic of viral pneumonia (coronavirus disease [COVID-19]), due to
the virus SARS-CoV-2, has infected millions of people and remains a threat to many more …

There is increasing evidence that novel coronavirus disease 2019 (COVID-19) leads to a
significant coagulopathy, a phenomenon termed “COVID-19 associated coagulopathy.” …

Since the onset of the global pandemic in early 2020, coronavirus disease 2019 (COVID-19)
has posed a multitude of challenges to health care systems worldwide. In order to combat …

The COVID‐19 pandemic has been the most significant health crisis in recent global history.
Early studies from Wuhan highlighted COVID‐19‐associated coagulopathy and a significant …

This illustrated review discusses the haemostatic changes seen in patients with severe
coronavirus disease 2019 (COVID‐19) infection and their possible causes. We discuss the …

COVID-19 is associated with endothelial activation in the setting of a potent inflammatory
reaction and a hypercoagulable state. The end result of this thromboinflammatory state is an …